We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AJP:GETTEXArtmarket.com SA Analysis

Data as of 2026-03-15 - not real-time

€2.83

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Artmarket.com trades at €2.83, just above its 20‑day SMA (2.80) but well below the 50‑day (3.00) and 200‑day (3.71) averages, confirming a bearish price bias. The stock hovers near its technical support at €2.61 and faces resistance around €2.91, while the RSI sits at 45 (neutral) and the MACD histogram shows a modest bullish tilt despite a negative MACD line. Volatility is elevated at over 34% and average daily volume is extremely thin, underscoring liquidity concerns.
Fundamentally, the company generates modest €8.36 M in revenue with only 1% growth, but maintains a strong gross margin of 61% and a thin profit margin of 7.6%. The price‑earnings multiple is a lofty 47× versus an industry average of 18×, and the discounted cash‑flow model values the firm at roughly €1.60, indicating significant overvaluation. The price‑to‑book ratio of 0.58 suggests the market price is below book value, yet a high debt‑to‑equity ratio of 3.14 and negative free cash flow raise solvency questions, and the firm does not pay a dividend.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Price near technical support with limited upside to resistance
  • Bearish longer‑term moving averages
  • Thin trading volume increasing execution risk

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Significant overvaluation relative to DCF and industry PE
  • High debt‑to‑equity ratio and negative free cash flow
  • Stable but flat revenue growth limiting earnings expansion

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Undervalued price‑to‑book ratio offering a potential margin of safety
  • Strong gross margins indicating resilient core business
  • Persistent high volatility and liquidity constraints

Key Metrics & Analysis

Financial Health

Revenue Growth1.00%
Profit Margin7.60%
P/E Ratio47.2
ROE1.99%
ROA0.78%
Debt/Equity3.14
P/B Ratio0.6
Op. Cash Flow€911.0K
Free Cash Flow€-64125
Industry P/E17.8

Technical Analysis

TrendBearish
RSI45.2
Support€2.61
Resistance€2.91
MA 20€2.80
MA 50€3.00
MA 200€3.71
MACDBullish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair Value€1.60
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.89
Volatility34.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.